Nelson Pharmaceuticals (NRx) is a privately owned drug company with headquarters in Cary, NC. The Company was founded in 2009 to develop and obtain FDA approval for innovative, enhanced drug therapies and related products focused on improving the quality of care for people with a chronic disease. Chronic diseases include anemia, diabetes, heart disease, kidney disease, osteoporosis, and Alzheimer's disease. NRx's exclusive drug and related therapies are designed to support disease management initiatives to improve the quality of life and care of people having chronic diseases and are designed to deliver safe and effective therapy while decreasing side effects experienced by the patient. Clinicians know that improving patient tolerability in this way significantly enhances patient compliance with dosage regimens.
As a result of significant
advances in the U.S.
health care system, both mortality and disability rates have fallen
consistently since the 1970's. Americans live longer and better lives. Despite
these advances, diseases such as heart disease, diabetes, kidney failure, and
osteoporosis continue to reduce our quality of life and cause untimely
death.Investments in the improvement of
existing drugs and for research into the discovery of new drugs will serve to
materially improve the world population's quality of life. Contact us for additional information.